Tissue engineering and regenerative medicine require biomaterials that support cellular proliferation, migration, and self-organization to develop functional tissue structures. Granular hydrogel ...

Hydrogels with particulates, including proteins, drugs, nanoparticles, and cells, enable the development of new and innovative biomaterials. Precise control of the spatial distribution of these ...

An update from Regentis Biomaterials Ltd ( ($RGNT) ) is now available. On December 18, 2025, Regentis Biomaterials announced that the U.S. Patent ...

A newly engineered hydrogel shows early promise for treating vocal cord injuries by persisting longer than existing injectable materials.

Herzliya, Israel, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Regentis Biomaterials Ltd. (NYSE American: RGNT) (“Regentis”, or the “Company”), a regenerative medicine company dedicated to developing innovative ...

Researchers are one step closer to bioprinting organs and tissues using a novel granular hydrogel bioink. Every 9 minutes a person is added to the organ transplant waiting list in the United States, ...

Zustiak’s primary research interests are in hydrogel biomaterials and tissue engineering, with emphasis on developing novel biomaterials as cell scaffolds and drug screening platforms, and elucidating ...

The dental pulp is susceptible to microbial infection, which often results in inflammation, necrosis, and defects in the pulp ...

Patent protects ready to use liquid formulation of GerlinC which improves efficiency and focus for surgeons, resulting in a 10-minute procedureRobust IP portfolio includes 35 issued patents to date wo ...

With a new durable composite hydrogel, researchers have 3D printed heart valves that last nearly 100 times as long as valves made with a simple hydrogel (Matter 2021, DOI: 10.1016/j.matt.2021.03.011).